The document discusses several key issues regarding ethics, legal issues, and consumer rights in laboratory medicine. It notes that diagnostic laboratories play a crucial role in clinical care but many have questionable quality. Common complaints against pathological labs include providing wrong reports, misleading information, overcharging, and poor hygiene. The document emphasizes that both clinicians and laboratories share responsibility in issues of mortality and morbidity. It outlines consumers' rights to file complaints under the Consumer Protection Act regarding problems with pathological labs. Improving laboratory standards, transparency, and accountability is important to better serve patients and public health.
Surveys a series of ethical, economic, clinical and also safety issues relating to the application of informatics to healthcare, focusing especially on the role of informatics in the Patient Protection and Affordable Care Act. Talk presented in the University at Buffalo Clinical/Research Ethics Seminar - Ethics, Informatics and Obamacare, November 20, 2012. Slides are available here: http://ontology.buffalo.edu/13/ethics-informatics-obamacare.pptx
Patient engagement in medical device studiesCOUCH Health
Not only will the industry see changes with the EU MDR, but we're glad that patients will recognise changes for the better, too. Patients can expect to make more informed decisions before using medical devices, as more information will become publicly available. And we think this is a big step in the right direction! Read more about our thoughts on involving patients more in the medical device clinical trial process:
Medicine: A State of CRISIS, a State of CHANGELouis Cady, MD
Dr. Cady returns this year to repeat and update one of the most talked about presentations of the 2015 IMMH conference. In this presentation, Dr. Cady deconstructs the pressures and challenges facing patients, physicians, and all health care practitioners in today's practice environment. The role of integrated practice and functional medicine as a "differentiating factor" in one's practice is reviewed. The need for patients to adapt a healthy life style and take responsibility for their health for their own economic self-preservation is also touched on.
REAL WORLD DATA SOURCES AND APPLICATIONS IN HEALTH OUTCOMES RESEARCH ClinosolIndia
Health outcomes research aims to assess the real-world effectiveness, safety, and value of healthcare interventions. In recent years, the availability and utilization of real-world data (RWD) have significantly contributed to advancing health outcomes research. This paper explores the various sources of real-world data and their applications in health outcomes research.
Real-world data refers to data collected outside of controlled clinical trials, often generated through routine healthcare delivery, electronic health records (EHRs), claims databases, registries, wearable devices, and patient-reported outcomes. These data sources provide a wealth of information on patient characteristics, treatment patterns, healthcare utilization, and clinical outcomes in real-world settings.
Surveys a series of ethical, economic, clinical and also safety issues relating to the application of informatics to healthcare, focusing especially on the role of informatics in the Patient Protection and Affordable Care Act. Talk presented in the University at Buffalo Clinical/Research Ethics Seminar - Ethics, Informatics and Obamacare, November 20, 2012. Slides are available here: http://ontology.buffalo.edu/13/ethics-informatics-obamacare.pptx
Patient engagement in medical device studiesCOUCH Health
Not only will the industry see changes with the EU MDR, but we're glad that patients will recognise changes for the better, too. Patients can expect to make more informed decisions before using medical devices, as more information will become publicly available. And we think this is a big step in the right direction! Read more about our thoughts on involving patients more in the medical device clinical trial process:
Medicine: A State of CRISIS, a State of CHANGELouis Cady, MD
Dr. Cady returns this year to repeat and update one of the most talked about presentations of the 2015 IMMH conference. In this presentation, Dr. Cady deconstructs the pressures and challenges facing patients, physicians, and all health care practitioners in today's practice environment. The role of integrated practice and functional medicine as a "differentiating factor" in one's practice is reviewed. The need for patients to adapt a healthy life style and take responsibility for their health for their own economic self-preservation is also touched on.
REAL WORLD DATA SOURCES AND APPLICATIONS IN HEALTH OUTCOMES RESEARCH ClinosolIndia
Health outcomes research aims to assess the real-world effectiveness, safety, and value of healthcare interventions. In recent years, the availability and utilization of real-world data (RWD) have significantly contributed to advancing health outcomes research. This paper explores the various sources of real-world data and their applications in health outcomes research.
Real-world data refers to data collected outside of controlled clinical trials, often generated through routine healthcare delivery, electronic health records (EHRs), claims databases, registries, wearable devices, and patient-reported outcomes. These data sources provide a wealth of information on patient characteristics, treatment patterns, healthcare utilization, and clinical outcomes in real-world settings.
Please follow instructions carefully. Thank you so kindly. Ass.docxmattjtoni51554
Please follow instructions carefully. Thank you so kindly.
Assignment 1 “Changes in Human Resource Management (HRM) and Employment Law" Please respond to the following: 1 and ½ half pages with references
· Based on the assigned chapters this week, identify three (3) key changes that have advanced HR and provide a justification to support your selection.
· From this week’s assigned reading, choose one (1) historical government HR regulation enacted and elaborate on how this new mandate affected all stakeholders involved. Recall stakeholders in any industry, and cover those directly involved and their communities.
Assignment 2 "Human Resources Activities and Relationships" Please respond to the following:
1 and ½ half pages with references
· Considering the services provided by a hospital HR department, how do most HR specialists deal with employee scarcity like nursing shortages when trying to hire the best professionals?
· What leadership and management skill sets are useful for retaining good employees and deferring employee turnover?
Assignment 3
Job Descriptions and Employee Training and Development" Please respond to the following:
2 pages with references
· Go to the Joint Commission’s Website located at http://www.jointcommission.org/standards_information/jcfaq.aspx. At “Standards FAQs,” select a field-related manual category from the drop-down list, type in “human resources” in the “Optional Keyword” box, and then click the “Go” button. Next, provide an example of how the Joint Commission has influenced a specific function of HR in a healthcare organization.
· Recommend a specific employee training method that you think would be most effective for a healthcare organization, and determine one advantage and one disadvantage of your chosen training method. Provide support for your rationale.
The New Focus on Quality and Outcomes
Introduction
In 1999, the Institute of Medicine (IOM) published a groundbreaking analysis of the impact of medical errors on the health care delivery system and the patients it serves. The analysis, published as "To Err is Human: Building a Safer Healthcare System," concluded that medical errors resulted in up to 98,000 patient deaths in American hospitals every year. This report hit the national press and participants in the health care system and the political system with the force of a large bomb. Since that time, hospitals and other health care entities have refocused their attention on quality, errors, and patient safety in an unprecedented way, urged on by public outcry and by federal and state efforts to compel improvements in the health care system. Such entities as the Institute for Healthcare Improvement (www.ihi.org) the National Quality Forum (www.qualityforum.org), and the Institute of Medicine (www.iom.edu) have all emerged as champions of quality and safety initiatives, offering training, resources, access to best practices, and data collection strategies to move the cause of quality.
BMJ Feature: Flipping the model for access to patient recordsPatients Know Best
Lack of progress in NHS England’s efforts to provide universal access to medical records has led to the development of independent initiatives, reports Ben Adams
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...PharmaLedger
In this presentation, you will find:
An introduction to the PharmaLedger project presented by Maria Eugenia (Xenia) Beltran | Project Coordinator / DRA and Use Case co-lead (Universidad Politécnica de Madrid)
Topic 1 | Clinical Trial eRecruitment | Despina Daliani (Onorach) and Ken Nessel (Pfizer)
Topic 2 | Clinical Trial eConsent | Hernando C. Giraldo (Boehringer Ingelheim) and Despina Daliani (Onorach)
Topic 3 | Health Data IoT Medical Device | Disa Lee Choun (UCB) and Francesca Rocchi (Bambino Gesù Children Hospital)
Topic 4 | Health Data Personalised Medicine | Beatriz Merino (Universidad Politécnica de Madrid) and Christos Kontogiorgis (Democritus University of Thrace)
You can also learn more about our #2 Open Webinar on Clinical Trials & Health Data by rewatching our video recording including the Q&A by clicking on the button below:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
NASSCOM CoE IoT spearheaded a high-level industry roundtable to discuss firsthand the challenges & opportunities in India’s clinical trial industry and how technology can accelerate development
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdfLucas Lagone
Explore digital transformation in Healthcare, Trends, face challenges, and discover effective solutions for a seamless transition in the healthcare industry.
Please follow instructions carefully. Thank you so kindly. Ass.docxmattjtoni51554
Please follow instructions carefully. Thank you so kindly.
Assignment 1 “Changes in Human Resource Management (HRM) and Employment Law" Please respond to the following: 1 and ½ half pages with references
· Based on the assigned chapters this week, identify three (3) key changes that have advanced HR and provide a justification to support your selection.
· From this week’s assigned reading, choose one (1) historical government HR regulation enacted and elaborate on how this new mandate affected all stakeholders involved. Recall stakeholders in any industry, and cover those directly involved and their communities.
Assignment 2 "Human Resources Activities and Relationships" Please respond to the following:
1 and ½ half pages with references
· Considering the services provided by a hospital HR department, how do most HR specialists deal with employee scarcity like nursing shortages when trying to hire the best professionals?
· What leadership and management skill sets are useful for retaining good employees and deferring employee turnover?
Assignment 3
Job Descriptions and Employee Training and Development" Please respond to the following:
2 pages with references
· Go to the Joint Commission’s Website located at http://www.jointcommission.org/standards_information/jcfaq.aspx. At “Standards FAQs,” select a field-related manual category from the drop-down list, type in “human resources” in the “Optional Keyword” box, and then click the “Go” button. Next, provide an example of how the Joint Commission has influenced a specific function of HR in a healthcare organization.
· Recommend a specific employee training method that you think would be most effective for a healthcare organization, and determine one advantage and one disadvantage of your chosen training method. Provide support for your rationale.
The New Focus on Quality and Outcomes
Introduction
In 1999, the Institute of Medicine (IOM) published a groundbreaking analysis of the impact of medical errors on the health care delivery system and the patients it serves. The analysis, published as "To Err is Human: Building a Safer Healthcare System," concluded that medical errors resulted in up to 98,000 patient deaths in American hospitals every year. This report hit the national press and participants in the health care system and the political system with the force of a large bomb. Since that time, hospitals and other health care entities have refocused their attention on quality, errors, and patient safety in an unprecedented way, urged on by public outcry and by federal and state efforts to compel improvements in the health care system. Such entities as the Institute for Healthcare Improvement (www.ihi.org) the National Quality Forum (www.qualityforum.org), and the Institute of Medicine (www.iom.edu) have all emerged as champions of quality and safety initiatives, offering training, resources, access to best practices, and data collection strategies to move the cause of quality.
BMJ Feature: Flipping the model for access to patient recordsPatients Know Best
Lack of progress in NHS England’s efforts to provide universal access to medical records has led to the development of independent initiatives, reports Ben Adams
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...PharmaLedger
In this presentation, you will find:
An introduction to the PharmaLedger project presented by Maria Eugenia (Xenia) Beltran | Project Coordinator / DRA and Use Case co-lead (Universidad Politécnica de Madrid)
Topic 1 | Clinical Trial eRecruitment | Despina Daliani (Onorach) and Ken Nessel (Pfizer)
Topic 2 | Clinical Trial eConsent | Hernando C. Giraldo (Boehringer Ingelheim) and Despina Daliani (Onorach)
Topic 3 | Health Data IoT Medical Device | Disa Lee Choun (UCB) and Francesca Rocchi (Bambino Gesù Children Hospital)
Topic 4 | Health Data Personalised Medicine | Beatriz Merino (Universidad Politécnica de Madrid) and Christos Kontogiorgis (Democritus University of Thrace)
You can also learn more about our #2 Open Webinar on Clinical Trials & Health Data by rewatching our video recording including the Q&A by clicking on the button below:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
NASSCOM CoE IoT spearheaded a high-level industry roundtable to discuss firsthand the challenges & opportunities in India’s clinical trial industry and how technology can accelerate development
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdfLucas Lagone
Explore digital transformation in Healthcare, Trends, face challenges, and discover effective solutions for a seamless transition in the healthcare industry.
Similar to ETHICAL, LEGAL AND CONSUMER ISSUES IN LABORAOTRY - Copy.pdf (20)
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
ETHICAL, LEGAL AND CONSUMER ISSUES IN LABORAOTRY - Copy.pdf
1. ETHICAL,, LEGAL, AND CONSUMER
ISSUES IN LABORAOTRY MEDICINE
Dr.T.V.Rao MD
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 1
2. I am grateful to
The authorities at Jagran Lakecity University and
Consumer Advocacy Group
Dr. Deevanshu Shrivastava, Head, Faculty of Law
Dr. PVVS Murthy, Founder, CAG
Dr. K. Pattabhiramaiah
Dr. Uday Prakash Warunjika
Ms. Madhu Latha
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 2
3. The talk will discuss
•Need for improved laboratory services
•Ethics and consumer rights in Laboratory
Medicine
•Who is responsible in Morality and
Morbidity issues
Is it clinician? or Laboratory?
•Consumer rights? WHERE ARE WE TODAY ?
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 3
4. MEDICINE IS MOVING FROM HUMAN
TOUCH TO MECHINE CARE
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 4
5. MEDICAL PROFESSION AND MEDICAL
NEGLIANCE ???
•Medical profession is considered to be a
noble profession however, it has been time
and again placed under scrutiny and so
have all persons working in this profession.
Medical negligence is considered to be one
of the most crucial concerns not just in our
country but throughout the world.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 5
6. Laboratory services and Impact on
Health care delivery
•Healthcare delivery and responsibility is changing.
Patient-centered care is gaining international
acceptance with the patient taking greater
responsibility for his/her health and sharing decision
making for the diagnosis and management of illness.
Laboratory medicine must embrace this change and
work in a tripartite collaboration with patients and
with the clinicians who use clinical laboratory
services. I
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 6
7. Clinical care Depends on Laboratory
standards
• Currently diagnosis and
management of patients in
Clinical Practice is very much
dependent on laboratory
diagnostics. Laboratory
Medicine, like any other
branch of Medicine, is
therefore, mandated with
ethical usage of materials and
data obtained from patients.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 7
8. Population and Health care
challenges
•But problems like higher
population density, low
socioeconomic status
and low literacy rate in
some parts of the
country, have resulted
in poor health
indicators.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 8
9. WHY THE ISSUES IN MEDICAL
PROFESSION ARE COMPLEX
•The medical profession is a bit different
from others for being in a noble and
respected area of work.
Thus, it is the legal responsibility of
Doctors and pathological laboratories
to provide the proper medical services
to the patients.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 9
10. COVID 19 WAKES UP ????
• But, in the Covid-19
pandemic time, citizens are
often facing negligence,
fraudulent actions from
the pathological labs,
Hospitals and even
physicians and
do not get the legal
pathway to claim justice
against the same.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 10
11. Fraud in Medical profession in
USA
•In June 2018, the US Department of Justice held
nearly 600 individuals, including doctors,
responsible for the largest healthcare fraud in the
US history resulting in losses of over US$2 billion.
Each year, the American healthcare system loses
tens of millions of dollars to fraudulent claims not
only overloading the healthcare system but also
affecting the security and identity of patients and
other citizens.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 11
13. POOR LABORATORY SERVICE THREAT
TO LIFE
• It is seen that a lot of times
the pathology labs fail to
provide the needed medical
aid that can be dangerous for
the patient too. As per the
legal directives of the
Consumer Protection
Act, 2019, of the Indian
Govt. we can file a complaint
against a Pathological Lab
meant for such
circumstances.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 13
14. New Consumer Protection law in India:
A Simple Overview
•On July 20th, 2020, the new Consumer Protection
Act, 2019 came into force in India, replacing the
previous enactment of 1986. The new Act overhauls
the administration and settlement of consumer
disputes in India. It provides for strict penalties,
including jail terms for adulteration and for
misleading advertisements. More
importantly, it now prescribes rules for the sale of
goods through e-commerce.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 14
15. We can file complaint
• As per the legal directives of
the Consumer Protection Act,
2019, of the Indian Govt. we
can file a complaint against a
Pathological Lab meant for
such circumstances. Common
Complaints against
Pathological Labs Wrong
reports made in Covid-19
cases Misleading information
and report
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 15
16. How diagnostic labs are failing patients in
India in terms of poor standards
•Between 2012 and 2019, there was a
nearly 200 per cent jump in the number
of diagnostic laboratories that have
accreditation, a gold standard which
offers an assurance to patients of
quality services and reliable reports.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 16
17. GROUND REALITIES ON
LABORATORYSERVICES
•While the figure gives hope,
especially as it concerns a sector
which has little to do with rules
and regulation,
The state of affairs on the
ground remains grim.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 17
18. WHO WILL APPROVE THE
LABORATORY REPORTS
•Laboratories put the decision to
treat in the Hands of the Clinicians
as all the laboratory results are
subject to clinical assessment
•So it difficult to file complaints on
Laboratory results
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 18
19. Error reporting in Laboratory
results
•Biochemistry common errors in Blood sugar
estimations lipid profiles and thyroid screening tests
•Screening for
•HIV ,Hepatitis B and C
•Blood Bank errors in Blood transfusions
•Genomic screenings in Genetic disorders
•Matters related to diagnosis of Cancers
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 19
20. Common Complaints against
Pathological Labs
• Wrong reports made in Covid-19 cases
• Misleading information and report
• Overcharging without any valid reason
• Interchange of Samples
• Mishandling the medical samples
• Misbehavior with the patients
• Illegal practice
•Unhygienic atmosphere
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 20
21. Diagnostic labs of questionable quality,
•The issue over diagnostic labs of questionable
quality, which have mushroomed in every
nook and cranny of our urban landscape, is so
grave that even NATHEALTH-Healthcare
Federation of India, an industry body,
highlighted it recently through a report titled,
‘An Assessment of India's Laboratory
Diagnostic Industry’.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 21
22. Concerns of Government of India on Medical
laboratories
•Dr VK Paul, member (health) Niti Aayog and the
chairperson of the Medical Council of India’s
Board of Governors, admitted that lack of
specified standards in infrastructure,
qualification and transparency in case of
laboratories is has been a “huge concern” for
the government.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 22
23. Errors in clinical laboratories or errors
in laboratory medicine?
•Laboratory testing is a highly
complex process and, although
laboratory services are
relatively safe, they are not as
safe as they could or should be
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 23
24. Future thinking to improve the
Laboratory services
•Clinical laboratories have long focused their
attention on quality control methods and
quality assessment programs dealing with
analytical aspects of testing. However, a
growing body of evidence accumulated in
recent decades demonstrates that quality in
clinical laboratories cannot be assured by
merely focusing on purely analytical aspects.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 24
25. Things going Wrong need better
Understanding of Laboratory system
•A description of the most frequent and risky pre-,
intra- and post-analytical errors and advice on
practical steps for measuring and reducing the risk of
errors
A recent document from the International
Organization for Standardization (ISO) recommends a
new, broader definition of the term "laboratory
error" and a classification of errors according to
different criteria.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 25
26. Laboratory system going wrong
Should be better
•Many mistakes in the Total Testing Process are called
"laboratory errors", although these may be due to
poor communication, action taken by others
involved in the testing process (e.g., physicians,
nurses and phlebotomists), or poorly designed
processes, all of which are beyond the laboratory's
control. Likewise, there is evidence that laboratory
information is only partially utilized
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 26
27. WHAT IS HAPPENING IS
NEED CORRECTION
•The primary reason is that numerous
cases have been reported where an
under qualified medical professional
has been taken under inquiry for not
taking reasonable care during the time
of operation, diagnosis, etc.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 27
28. Ethics and Responsibilities of Medical
Lab Technologists
•Place the well-being and service for the sick above
your own interests.
•Be loyal to your medical laboratory profession by
maintaining high standards of work and strive to
improve your professional knowledge.
•Work scientifically and with complete honesty.
•Do not misuse your professional skills or knowledge
for personal gain.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 28
29. Do not Do it
• Do not disclose to a patient
or any unauthorized person
the result to your
investiga¬tions.
• Treat with utmost
confidentiality and personal
information that you may
learn about a patient.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 29
30. Ethics and Competency back bone of
Labotaroy success
• Respect and work in harmony with the other members of your hospital
staff or health center team.
• Be at all times courteous, patient and considerate to the sick and their
relations.
• Promote health care and the prevention and control of disease.
• Follow safety procedures and know how to apply first aid.
• Do not drink alcohol during laboratory working hours or when on
emergency stand by.
• Use equipment and laboratory-ware correctly and with care.
• Do not waste reagents or other laboratory supplies.
• Fulfil reliably and completely the terms and conditions of your
employment.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 30
31. Known facts on Laboratories in India
• Of the nearly 1.1 lakh medical laboratories in the country,
whose test reports determine over 70 per cent of medical
decisions, just about 1,039 are accredited.
• The issue over diagnostic labs of questionable quality,
which have mushroomed in every nook and cranny of our
urban landscape, is so grave that even NATHEALTH-
Healthcare Federation of India, an industry body,
highlighted it recently through a report titled, ‘An
Assessment of India's Laboratory Diagnostic Industry’.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 31
32. Recent status on Laboratories in India
•From the last few years, we have witnessed
numerous pathological labs have been set up
without proper registration and people are suffering
due to their illegal activities at the end. The patients
pay a huge amount of money and then the Labs take
advantage of their legal unawareness! It is not
possible for everyone to know about the lawful
procedures to file a pathological lab complaint in the
Consumer Court.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 32
33. Who is responsible in MorTality and Morbidity
issues
is it clinician? or Laboratory?
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 33
34. What is a Consumer Complaint?
• Consumers who pay for a
specific good or service have the
right to take legal action if they
receive subpar products or
subpar services. The Consumer
Protection Act of 1986
MODIFIED IN 2020 gives
consumers various legal rights
and protections. According to
this Act, the customer may take
a business or service provider to
court with a formal complaint.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 34
35. online consumer complaint
• An online consumer complaint is
what this specific issue is known
as. If the business ignores a legal
warning to correct the problem, a
complaint is typically made. All
necessary information and
accompanying documentation
must be submitted when
registering a complaint. The
consumer courts in India offer
clients prompt legal counsel and
decisions.
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 35
36. MONEY MONEY MONEY MATTERS REST
IS YOUR CHOICEN
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 36
37. Be Aware that we can utilize our Rights
•SEND A NOTICE MENTIONING THE
PROBLEM/ FAULT YOU FACED
•WAIT FOR A RESPONSE FROM THE VENDOR
•SELECT THE CORRECT FORUM
•SUBMIT A WRITTEN COMPLAINT
•PAY THE COURT FEE
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 37
38. GOVERNMENT WISHES TO PROTECT
EVERYONES RIGHTS
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 38
39. References
• Online legal India
• Ethics in Laboratory Medicine: Perspectives and Challenges
in Resource Limited Settings
• Press trust of India reports in National domain
• CDC Atlanta
• Human rights and health care
• Open sources credited reviewed information Google
19-09-2023 Dr.T.V.Rao MD @ Laboratory consumer issues 39